Oncology Drugs Industry

Oncology Drugs Industry Development Trend Analysis Report 2024

Oncology Drugs Industry

Oncology Drugs Industry Development Trend Analysis Report 2024


Analysis of the Oncology Drugs Market reveals emerging trends, consumer adoption rates, and competitive strategies among leading manufacturers worldwide.

Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!

The global Oncology Drugs market size in 2023 is 156700.0 million US dollars, and it is expected to be 256606.1 million US dollars by 2030, with a compound annual growth rate of 7.30% expected in 2024-2030.

MARKET COMPETITIVE LANDSCAPE:

The main players in the Oncology Drugs market include Abbvie Inc., Amgen, Inc., AstraZeneca PLC, F. Hoffmann-La Roche Ltd, and Johnson & Johnson Services, Inc.. The share of the top 3 players in the Oncology Drugs market is XX%.

REGION SHARE:

The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Oncology Drugs market, and Asia Pacific accounted for XX%.

SEGMENT OVERVIEW:

The report segments the market by Type and Application. Oral accounted for XX% of Oncology Drugs market in 2023. Parenteral share of XX%.

Hospitals accounted for XX% of the Oncology Drugs market in 2023. Clinics accounts for XX%.

The report includes the analysis of impact of COVID-19 lock-down on the revenue of market leaders, followers, and disrupters. Since lock down was implemented differently in different regions and countries, impact of same is also different by regions and segments. The report has covered the current short term and long term impact on the market, same will help decision makers to prepare the outline for short term and long term strategies for companies by region.

The objective of the report is to present a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, industry-validated market data and projections with a suitable set of assumptions and methodology. The report also helps in understanding Global Oncology Drugs Market dynamics, structure by identifying and analyzing the market segments and project the global market size.

In addition, the market SWOT analysis, dynamics, trends, technologies, opportunities and challenges analysis are covered in the report.

Further, the report also focuses on the competitive analysis of key players by product, financial position, product portfolio, growth strategies, and regional presence.

 

Chapter Outline

Chapter 1: Introduces the product overview, market scope, product classification, and application division, and then includes research purposes, report timeline, and economic analysis of global regions.

Chapter 2: Analyzes the Oncology Drugs manufacturing cost, including raw material analysis, manufacturing cost structure, and industrial chain.

Chapters 3-5: Segmented the global Oncology Drugs market by type, application and region. Analyze the revenue, sales and price of market segments from different perspectives.

Chapters 6-11: Provide North America, Europe, China, Asia-Pacific, Latin America and Middle East & Africa Oncology Drugs market type, application, country and players market segmentation data.

Chapter 12: Analyzes the Oncology Drugs industry chain, including marketing channels, distributors and major downstream buyers.

Chapter 13: Introduces the market dynamics, the trends factors and drivers factors of the market, and the challenges and restraints faced by manufacturers in the industry, and includes industry mergers & acquisitions and industry new entrants and expansion plans.

Chapter 14: Analyzes the main companies in the Oncology Drugs industry, including their main businesses, products/services, sales, prices, revenue and gross margin.

Chapter 15: The main points and conclusions of the report.

Highlights-Regions

North America

United States

Canada

China

Asia Pacific (Excluding China)

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Nordic

Latin America

Brazil

Argentina

Mexico

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

Player list

Abbvie Inc.

Amgen, Inc.

AstraZeneca PLC

F. Hoffmann-La Roche Ltd

Johnson & Johnson Services, Inc.

Merck & Co., Inc.

Novartis AG

Others

Types list

Oral

Parenteral

Others

Application list

Hospitals

Clinics

Specialty Centers

Research Institutes

Others

Table of Content

1 Oncology Drugs Market Introduction and Overview

1.1 Oncology Drugs Definition

1.2 Market Size Analysis by Types

1.3 Market Size Analysis by Application

1.4 Research Purposes

1.5 Report Timeline

1.6 Economic Analysis of Global Regions

2 Oncology Drugs Manufacturing Cost Analysis

2.1 Oncology Drugs Key Raw Materials Analysis

2.1.1 Key Raw Materials

2.1.2 Price Trend of Key Raw Materials

2.1.3 Key Suppliers of Raw Materials

2.2 Proportion of Manufacturing Cost Structure

2.2.1 Raw Materials

2.2.2 Labor Cost

2.2.3 Manufacturing Expenses

2.3 Manufacturing Process Analysis of Oncology Drugs

2.4 Oncology Drugs Industrial Chain Analysis

3 Global Oncology Drugs Historical and Forecast Market Analysis by Type

3.1 Global Oncology Drugs Revenue and Market Share by Type

3.2 Global Oncology Drugs Sales and Market Share by Type

3.3 Global Oncology Drugs Revenue Market Forecast by Type (2024-2030)

3.4 Global Oncology Drugs Sales Market Forecast by Type (2024-2030)

4 Global Oncology Drugs Historical and Forecast Market Analysis by Application

4.1 Global Oncology Drugs Revenue Market Share by Application (2019-2024)

4.2 Global Oncology Drugs Sales Market Share by Application (2019-2024)

4.3 Oncology Drugs Revenue Market Forecast by Application (2024-2030)

4.4 Oncology Drugs Sales Market Forecast by Application (2024-2030)

5 Global Market Growth Trends Analysis

5.1 Global Oncology Drugs Market Size & Forecast (2019-2030)

5.2 Oncology Drugs Growth Trends Analysis by Regions

5.2.1 Oncology Drugs Market Size by Regions: 2019 VS 2024 VS 2030

5.2.2 Oncology Drugs Historic Market Size by Regions (2019-2024)

5.2.3 Oncology Drugs Forecasted Market Size by Regions (2024-2030)

5.2.4 North America Oncology Drugs Market Size & Forecast (2019-2030)

5.2.5 Europe Oncology Drugs Market Size & Forecast (2019-2030)

5.2.6 China Oncology Drugs Market Size & Forecast (2019-2030)

5.2.7 Asia-Pacific (Excluding China) Oncology Drugs Market Size & Forecast (2019-2030)

5.2.8 Latin America Oncology Drugs Market Size & Forecast (2019-2030)

5.2.9 Middle East & Africa Oncology Drugs Market Size & Forecast (2019-2030)

6 North America

6.1 North America Oncology Drugs Revenue by Players

6.2 North America Oncology Drugs Sales by Types

6.3 North America Oncology Drugs Sales by Applications

6.4 North America Oncology Drugs Market by Countries

6.4.1 North America Oncology Drugs Revenue by Countries (2019-2030)

6.4.2 North America Oncology Drugs Sales by Countries (2019-2030)

6.5 United States

6.6 Canada

7 China

7.1 China Oncology Drugs Revenue by Players

7.2 China Oncology Drugs Sales by Types

7.3 China Oncology Drugs Sales by Applications

7.4 China

8 Asia Pacific (Excluding China)

8.1 Asia Pacific Oncology Drugs Revenue by Players

8.2 Asia Pacific Oncology Drugs Sales by Types

8.3 Asia Pacific Oncology Drugs Sales by Applications

8.4 Asia Pacific Oncology Drugs Market by Countries

8.4.1 Asia Pacific Oncology Drugs Revenue by Countries (2019-2030)

8.4.2 Asia Pacific Oncology Drugs Sales by Countries (2019-2030)

8.5 Japan

8.6 Korea

8.7 Southeast Asia

8.8 India

8.9 Australia

9 Europe

9.1 Europe Oncology Drugs Revenue by Players

9.2 Europe Oncology Drugs Sales by Types

9.3 Europe Oncology Drugs Sales by Applications

9.4 Europe Oncology Drugs Market by Countries

9.4.1 Europe Oncology Drugs Revenue by Countries (2019-2030)

9.4.2 Europe Oncology Drugs Sales by Countries (2019-2030)

9.5 Germany

9.6 France

9.7 UK

9.8 Italy

9.9 Russia

9.10 Nordic

10 Latin America

10.1 Latin America Oncology Drugs Revenue by Players

10.2 Latin America Oncology Drugs Sales by Types

10.3 Latin America Oncology Drugs Sales by Applications

10.4 Latin America Oncology Drugs Market by Countries

10.4.1 Latin America Oncology Drugs Revenue by Countries (2019-2030)

10.4.2 Latin America Oncology Drugs Sales by Countries (2019-2030)

10.5 Brazil

10.6 Argentina

10.7 Mexico

11 Middle East & Africa

11.1 Middle East & Africa Oncology Drugs Revenue by Players

11.2 Middle East & Africa Oncology Drugs Sales by Types

11.3 Middle East & Africa Oncology Drugs Sales by Applications

11.4 Middle East & Africa Oncology Drugs Market by Countries

11.4.1 Middle East & Africa Oncology Drugs Revenue by Countries (2019-2030)

11.4.2 Middle East & Africa Oncology Drugs Sales by Countries (2019-2030)

11.5 Egypt

11.6 South Africa

11.7 Israel

11.8 Turkey

11.9 GCC Countries

12 Market Channel, Distributors, Traders and Dealers

12.1 Market Channel Status

12.1.1 Direct Marketing

12.1.2 Indirect Marketing

12.2 Oncology Drugs Typical Distributors

12.3 Oncology Drugs Typical Customers

13 Oncology Drugs Industry Dynamic Analysis

13.1 Oncology Drugs Market Trends Analysis

13.2 Oncology Drugs Market Drivers Analysis

13.3 Oncology Drugs Market Challenges Analysis

13.4 Oncology Drugs Market Restraints Analysis

13.5 Oncology Drugs Industry Mergers & Acquisitions

13.6 Oncology Drugs Industry New Entrants and Expansion Plans

14 Players Profiles

14.1 Abbvie Inc.

14.1.1 Abbvie Inc. Company Profile

14.1.2 Oncology Drugs Product Overview

14.1.3 Abbvie Inc. Oncology Drugs Market Performance (2019-2024)

14.1.4 Abbvie Inc. Business Overview

14.2 Amgen, Inc.

14.2.1 Amgen, Inc. Company Profile

14.2.2 Oncology Drugs Product Overview

14.2.3 Amgen, Inc. Oncology Drugs Market Performance (2019-2024)

14.2.4 Amgen, Inc. Business Overview

14.3 AstraZeneca PLC

14.3.1 AstraZeneca PLC Company Profile

14.3.2 Oncology Drugs Product Overview

14.3.3 AstraZeneca PLC Oncology Drugs Market Performance (2019-2024)

14.3.4 AstraZeneca PLC Business Overview

14.4 F. Hoffmann-La Roche Ltd

14.4.1 F. Hoffmann-La Roche Ltd Company Profile

14.4.2 Oncology Drugs Product Overview

14.4.3 F. Hoffmann-La Roche Ltd Oncology Drugs Market Performance (2019-2024)

14.4.4 F. Hoffmann-La Roche Ltd Business Overview

14.5 Johnson & Johnson Services, Inc.

14.5.1 Johnson & Johnson Services, Inc. Company Profile

14.5.2 Oncology Drugs Product Overview

14.5.3 Johnson & Johnson Services, Inc. Oncology Drugs Market Performance (2019-2024)

14.5.4 Johnson & Johnson Services, Inc. Business Overview

14.6 Merck & Co., Inc.

14.6.1 Merck & Co., Inc. Company Profile

14.6.2 Oncology Drugs Product Overview

14.6.3 Merck & Co., Inc. Oncology Drugs Market Performance (2019-2024)

14.6.4 Merck & Co., Inc. Business Overview

14.7 Novartis AG

14.7.1 Novartis AG Company Profile

14.7.2 Oncology Drugs Product Overview

14.7.3 Novartis AG Oncology Drugs Market Performance (2019-2024)

14.7.4 Novartis AG Business Overview

14.8 Others

14.8.1 Others Company Profile

14.8.2 Oncology Drugs Product Overview

14.8.3 Others Oncology Drugs Market Performance (2019-2024)

14.8.4 Others Business Overview

15 Research Findings and Conclusion

Tables & Figures:
Show more
Research Methodology:
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Oncology Drugs Market Size Estimation

To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.

Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.

Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.

We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.

Data Source

Secondary Sources

This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.

These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.

Market Size
  • Segmental value
  • Geographic Penetration
  • Product Adoption Rate for Different market
  • Journals, Websites, and Press Releases
  • Annual Reports and SEC Filings
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Market Intellix Data Repository
Market Position of Top Company
  • Product Financials
  • Geographic value Mix
  • Total Company value
  • Business/Segmental value Mix
Qualitative Analysis
  • Influence Factors
  • Market Potential
  • Market Risks and Opportunities
  • Industry Trends
  • Geographical Features
  • Government Policies
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Annual Reports
  • Industry Associations
  • Market Intellix Data Repository

Primary Sources

As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.

On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.

These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.

Key Data Information from Primary Sources

Primary Sources Parameters Key Data
Market Segments(by Application, by Type)
  • Value by Type
  • Status and Forecast
  • Value by Application
  • Value by Regions, Status and Forecast (2025-2031)
  • Value Market Share by Type
  • Value Growth Rate by Type
  • Value by Application
  • Percentage and Growth Rate by Application
  • Value Growth Rate and Market Share by Regions
  • Market Size Status and Forecast (2025-2031)
Total Market
  • Overall Size, Status and Forecast
  • Market Size Status and Forecast (2025-2031)
Frequently asked questions(FAQ's):
How are players chosen for the research coverage of the Oncology Drugs Market study?
MI used a variety of industry standards such as NAICS, ICB, TRIC, and others to identify functional players in the industry, which they then shortlist and validate in an iterative process to finalize the most relevant players.
What are the major applications for Oncology Drugs?
Oncology Drugs has a wide range of applications, including and others.
What is the forecasted growth rate of the Oncology Drugs Market?
The Oncology Drugs Market is expected to grow at a moderate CAGR during the forecast period of 2025 to 2030.
What does the future hold for the Oncology Drugs Market?
As the shift to value addition continues, companies in the Oncology Drugs Market face the dual challenge of improving interoperability to optimize performance and experience.
What is the estimated global market value of the Oncology Drugs Market?
The Oncology Drugs Market is expected to reach a considerable market valuation.